» Articles » PMID: 23637229

Regulation of Rad17 Protein Turnover Unveils an Impact of Rad17-APC Cascade in Breast Carcinogenesis and Treatment

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 May 3
PMID 23637229
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant regulation of DNA damage checkpoint function leads to genome instability that in turn can predispose cellular tissues to become cancerous. Previous works from us and others demonstrated the role of Rad17 in either activation or termination of DNA damage checkpoint function. In the current study, we have revealed the unexpected accumulation of Rad17 in various types of breast cancer cell lines as well as human breast cancer tissues. We observed that Rad17 protein turnover rate in breast epithelial cells is much faster than in breast cancer cells, where the turnover of Rad17 is regulated by the Cdh1/APC pathway. We further observed that Rad17-mediated checkpoint function is modulated by proteolysis. Stabilization of Rad17 disrupts cellular response to chemotherapeutic drug-induced DNA damage and enhances cellular transformation. In addition, manipulation of Rad17 by RNA interference or stabilization of Rad17 significantly sensitize breast cancer cell to various chemotherapeutic drugs. Our present results indicate the manipulation of Rad17 proteolysis could be a valuable approach to sensitize breast cancer cell to the chemotherapeutic treatment despite of the critical role in governing DNA damage response and cellular recovery from genotoxic stress.

Citing Articles

Emerging roles of i-motif in gene expression and disease treatment.

Luo X, Zhang J, Gao Y, Pan W, Yang Y, Li X Front Pharmacol. 2023; 14:1136251.

PMID: 37021044 PMC: 10067743. DOI: 10.3389/fphar.2023.1136251.


TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity.

Liu Q, Chung S, Murata M, Han B, Gao B, Zhang M Int J Biol Sci. 2022; 18(10):4203-4218.

PMID: 35844787 PMC: 9274500. DOI: 10.7150/ijbs.70583.


The noncoding function of NELFA mRNA promotes the development of oesophageal squamous cell carcinoma by regulating the Rad17-RFC2-5 complex.

Xu J, Wang G, Gong W, Guo S, Li D, Zhan Q Mol Oncol. 2019; 14(3):611-624.

PMID: 31845510 PMC: 7053240. DOI: 10.1002/1878-0261.12619.


Effect of ghost pepper on cell proliferation, apoptosis, senescence and global proteomic profile in human renal adenocarcinoma cells.

Perla V, Nadimi M, Reddy R, Hankins G, Nimmakayala P, Harris R PLoS One. 2018; 13(10):e0206183.

PMID: 30379886 PMC: 6209291. DOI: 10.1371/journal.pone.0206183.


Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis.

Zhou Z, Luo A, Shrivastava I, He M, Huang Y, Bahar I EBioMedicine. 2017; 15:48-61.

PMID: 28040451 PMC: 5233825. DOI: 10.1016/j.ebiom.2016.12.014.


References
1.
Zhang L, Park C, Wu J, Kim H, Liu W, Fujita T . Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress. EMBO J. 2010; 29(10):1726-37. PMC: 2876963. DOI: 10.1038/emboj.2010.55. View

2.
Knuesel M, Wan Y, Xiao Z, Holinger E, Lowe N, Wang W . Identification of novel protein-protein interactions using a versatile mammalian tandem affinity purification expression system. Mol Cell Proteomics. 2003; 2(11):1225-33. DOI: 10.1074/mcp.T300007-MCP200. View

3.
Nouspikel T . Nucleotide excision repair and neurological diseases. DNA Repair (Amst). 2008; 7(7):1155-67. DOI: 10.1016/j.dnarep.2008.03.015. View

4.
Tutt A, Robson M, Garber J, Domchek S, Audeh M, Weitzel J . Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet. 2010; 376(9737):235-44. DOI: 10.1016/S0140-6736(10)60892-6. View

5.
Siede W, Nusspaumer G, Portillo V, Rodriguez R, Friedberg E . Cloning and characterization of RAD17, a gene controlling cell cycle responses to DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res. 1996; 24(9):1669-75. PMC: 145842. DOI: 10.1093/nar/24.9.1669. View